Structural Investigation of the Antibiotic and ATP-Binding Sites in Kanamycin Nucleotidyltransferase+Y$

Total Page:16

File Type:pdf, Size:1020Kb

Structural Investigation of the Antibiotic and ATP-Binding Sites in Kanamycin Nucleotidyltransferase+Y$ Biochemistry 1995, 34, 13305-1331 1 13305 Structural Investigation of the Antibiotic and ATP-Binding Sites in Kanamycin Nucleotidyltransferase+y$ Lars C. Pedersen, Matthew M. Benning, and Hazel M. Holden* Institute for Enzyme Research, Graduate School, and Department of Biochemistry, Uniuersity of Wisconsin, Madison, Wisconsin 53705 Receiued June 28, 1995; Reuised Manuscript Receiued July 27, 1995@ ABSTRACT: Kanamycin nucleotidyltransferase (KNTase) is a plasmid-coded enzyme responsible for some types of bacterial resistance to aminoglycosides. The enzyme deactivates various antibiotics by transferring a nucleoside monophosphate group from ATP to the 4'-hydroxyl group of the drug. Detailed knowledge of the interactions between the protein and the substrates may lead to the design of aminoglycosides less susceptible to bacterial deactivation. Here we describe the structure of KNTase complexed with both the nonhydrolyzable nucleotide analog AMPCPP and kanamycin. Crystals employed in the investigation were grown from poly(etky1ene glycol) 2olutions and bFlonged to the space group P212121 with unit cell dimensions of a = 57.3 A, b = 102.2 ,A, c = 101.8 A, and one dimer in the asymmetric unit. Least- squares refinement of the model at 2.5 A resolution reduced the crystallographic R factor to 16.8%. The binding pockets for both the nucleotide and the antibiotic are extensively exposed to the solvent and are composed of amino acid residues contributed by both subunits in the dimer. There are few specific interactions between the protein and the adenine ring of the nucleotide; rather the AMPCPP molecule is locked into position by extensive hydrogen bonding between the a-, p-, and y-phosphates and protein side chains. This, in part, may explain the observation that the enzyme can utilize other nucleotides such as GTP and UTP. The 4'-hydroxyl group of the antibiotic is approximately 5 A from the a-phosphorus of the nucleotide and is in the proper orientation for a. single in-line displacement attack at the phosphorus. Glu 145, which lies within hydrogen-bonding distance of the 4'-hydroxyl group, is proposed to be the active site base. Aminoglycoside antibiotics consist of amino sugars linked to an aminocyclitol moiety through glycosidic bonds as no shown in Figure 1. The bactericidal effect of these com- pounds is believed to occur through their irreversible binding to the bacterial ribosomes (Moellering, 1983). Although there are newer, less toxic compounds on the market, the aminoglycosides still play useful roles in the treatment of serious infections caused by a broad range of microorganisms (Edson & Terrel, 1991; Johnson & Hardin, 1992). Unfor- tunately, due to past widespread usage of these antibiotics in clinical settings, bacterial strains have emerged that render these compounds ineffective. Resistance to aminoglycosides FIGURE1: General structure of the antibiotic kanamycin. Kana- is typically conferred by the enzymatic activity of plasmid- mycins A and B differ only at the 2'-position as indicated. Both coded acetyltransferases, phosphotransferases,and nucleoti- the 4'- and the 4"-hydroxyl groups are susceptible to nucleotid- dyltransferases [for a review, see Shaw et al. (1993)l. ylation by KNTase. Kanamycin nucleotidyltransferase (KNTase) is one such The three-dimensional structure of KNTase was recently enzyme and catalyzes the transfer of a nucleoside mono- determined by X-ray crystallographic techniques (Sakon et phosphate group from a nucleotide to the 4'-hydroxyl group al., 1993). From this structural study it was shown that the of kanamycin. First isolated from Staphylococcus aureus, enzyme was dimeric rather than monomeric as originally the enzyme can utilize ATP, GTP, or UTP as the nucleoside believed (Sadaie et al., 1980). The individual subunits of monophosphate donor and is capable of deactivating a KNTase are remarkably extended as shown in Figure 2a and number of different aminoglycosides (Le Goffic et al., can be described in terms of two structural domains. The N-terminal domain, delineated by Met 1 to Glu 127, is 1976a,b; Davies & Smith, 1978). characterized by a five-stranded mixed /3-pleated sheet whereas the C-terminal motif, formed by Ala 128 to Phe +This research was supported in part by a grant from the NIH 253, contains five a-helices, four of which form an up-and- (DK47814). down a-helical bundle. As can be seen in Figure 2b, the X-ray coordinates have been deposited with the Brookhaven Protein two subunits interact extensively by wrapping around one Data Bank under the filename 1KNY. * To whom correspondence should be addressed. another to form a rather large cavity which can easily @ Abstract published in Advance ACS Abstracts, October 1, 1995. accommodate a variety of aminoglycosides. On the basis 0006-2960/95/0434-13305$09.00/0 0 1995 American Chemical Society 13306 Biochemist?y, Vol. 34, No. 41, 1995 Pedersen et al. FIGURE2: Ribbon representation of the apo form of KNTase. Models for the individual monomer and the dimer of KNTase are shown in panels a (top) and b (bottom), respectively. The domains depicted in blue and yellow belong to subunit I; those in red and green represent subunit 11. This figure was prepared with the software package MOLSCRIPT (Kraulis, 1991). of this initial structural investigation, the two active sites These cells were stored at -70 "C prior to use. The enzyme for the KNTase homodimer were tentatively located and purification scheme employed was a modification of previ- shown to be formed by both subunits (Sakon et al., 1993). ously reported procedures and included an initial chromato- Here we describe the three-dimensional structure of graphic step with a DEAE-Sephadex-6505 column followed KNTase complexed with AMPCPP, a nonhydrolyzable by a TSK phenyl-SPW hydrophobic column and subsequent analog of ATP, and kanamycin. This structural investigation use of an HPLC Mono-Q HR10/10 column (Liao et al., 1986; provides a more complete description of the active site of Liao, 1991; Sadie et al., 1980; Sakon et al., 1993). The this enzyme and reveals both important protein-nucleotide purified protein was stored in 10 mM Tris-HC1, pH 7.5 at and protein-antibiotic interactions. Detailed structural -20 "C. Thus far it has not been possible to obtain X-ray information concerning the active site of KNTase may quality crystals for the wild-type enzyme. ultimately lead to the design of new and more effective aminoglycosides and possibly to the production of KNTase Prior to crystallization, the protein, at 15 mg/ml, was inhibitors. This is especially important in light of both the incubated with 10 mM kanamycin A for 1 h at 4 "C. X-ray alarming and rapid increase in the emergence of antibiotic- diffraction quality crystals were obtained by the hanging drop resistant bacterial strains and the lack of significant new method of vapor diffusion. For such experiments, 5 pL of antibiotics appearing on the pharmaceutical market. the protein- kanamycin solution was mixed on silanized coverslips with 5 pL of a solution containing 12.5% PEG MATERIALS AND METHODS 3350, 150 mM MgC12, 5 mM NaN3, and 100 mM Hepes Purijtcation and Ciystallization Procedures. The KNTase (pH 7.7). These droplets were equilibrated against the 12.5% mutant, D80Y, was expressed in the Escherichia coli PEG solution. Crystals generally appeared within 1 week overproducing strain BL2 1(DE3) carrying the expression with some achieving maximum dimensions of 0.3 mm x plasmid pX(T7)TKl (Studier & Moffatt, 1986; Liao, 1991). 0.3 mm x 0.7 mm. Active Site of Kanamycin Nucleotidyltransferase Biochemistry, Vol. 34, No. 41, 1995 13307 Table 1: Intensity Statistics for the Native X-ray Data resolution range (A) native overall 100.00-5.00 3.97 3.47 3.15 2.92 2.15 2.61 2.50 no. of measurements 51522 7655 7898 7331 6580 5992 5708 5299 5059 no. of independent reflections 20767 2513 2548 2590 2600 2611 2641 2626 2638 completeness of data (%) 81 84 89 90 88 83 16 IO 65 av intensity 457 1 9095 10000 5980 3266 1673 976 666 487 av u 438 366 499 473 443 424 42 1 429 442 R factor" (5%) 5 .O 3.5 3.4 4.5 6.8 11.1 17.0 21.9 29.1 Prior to X-ray data collection, the crystals were transferred Table 2: Least-Squares Refinement Statistics to a solution containing 14% PEG 3350, 150 mM MgC12, 5 resolution limits (A) 30.0-2.5 mM NaN3, 100 mM Hepes (pH 7.7), 20 mM kanamycin A, R factor" (%)a 16.8 and 5 mM adenosine 5'-a,P-methylenetriphosphate (AMP- no. of reflections used 19 405 no. of protein atoms 4187 CPP). To minimize crystal cracking, the concentration of no. of solvent atoms 46 AMPCPP was slowly increased to 10 mM and finally to 16 weighted rms deyiations from ideality mM over a period of 2 h. Crystals were soaked in this bond length (A) 0.014 kanamycin-AMPCPP solution for 24 h. On the basis of bond angle (deg) 2.5 precession photography, the crystals were shown to belong planarity (trigonal) (A) 0.006 planarity (other planes) (A) 0.012 to the space group P212121 with unit cell dimensions of a = torsional angleb (deg) 19.2 57.3 A, b = 102.2 A, c = 101.8 A, and one dimer in the R factor = ZIFo - FclE1F,J, where F, is the observed structure asymmetric unit. factor amplitude and F, is the calculated structure factor amplitude. X-ray Data Collection and Processing. X-ray diffraction The torsional angles were not restrained during the refinement. data were collected to 2.5 A resolution at 4 "C with a Siemens XlOOOD area detector system equipped with double- RESULTS AND DISCUSSION focusing mirrors. The X-ray source was Cu Ka radiation from a Rigaku RU200 rotating anode generator operated at The original model of KNTase was derived from crystals 50 kV and 50 mA.
Recommended publications
  • Genome Analysis and Classification of Novel Species Flavobacterium Gabrieli
    NOTICE: The copyright law of the United States (Title 17, United States Code) governs the making of reproductions of copyrighted material. One specified condition is that the reproduction is not to be "used for any purpose other than private study, scholarship, or research." If a user makes a request for, or later uses a reproduction for purposes in excess of "fair use," that user may be liable for copyright infringement. RESTRICTIONS: This student work may be read, quoted from, cited, for purposes of research. It may not be published in full except by permission of the author. 1 Kirsten Fischer Introduction Microbial Systematics and Taxonomy The diversity of bacteria is truly immense and the discovery of new species and higher taxonomic groups happens quite frequently, as evidenced by the ever expanding tree of life (Hug et al., 2016). The classification of prokaryotes, bacteria especially, is formally regulated by the International Committee on the Systematics of Prokaryotes and has experienced rapid change over the last fifty years. However, some feel that these rules could be even stricter for proper organization of taxonomy (Tindall et al., 2010). Problems occur with the integration of newer methodologies, which creates some challenges for the researcher attempting to publish a novel species. For example, some DNA sequences that are deposited in databases are not accurate (Clarridge, 2004). Taxonomy is an artificial system that works based on the intuition of scientists rather than strict, specific standards (Konstantinidis & Tiedje, 2005). Tindall advocates that a strain shown to be a novel taxon should be characterized “as comprehensively as possible” and abide by the framework established in the Bacteriological Code (2010).
    [Show full text]
  • Supplementary Materials
    Supplementary Materials Figure S1. Differentially abundant spots between the mid-log phase cells grown on xylan or xylose. Red and blue circles denote spots with increased and decreased abundance respectively in the xylan growth condition. The identities of the circled spots are summarized in Table 3. Figure S2. Differentially abundant spots between the stationary phase cells grown on xylan or xylose. Red and blue circles denote spots with increased and decreased abundance respectively in the xylan growth condition. The identities of the circled spots are summarized in Table 4. S2 Table S1. Summary of the non-polysaccharide degrading proteins identified in the B. proteoclasticus cytosol by 2DE/MALDI-TOF. Protein Locus Location Score pI kDa Pep. Cov. Amino Acid Biosynthesis Acetylornithine aminotransferase, ArgD Bpr_I1809 C 1.7 × 10−4 5.1 43.9 11 34% Aspartate/tyrosine/aromatic aminotransferase Bpr_I2631 C 3.0 × 10−14 4.7 43.8 15 46% Aspartate-semialdehyde dehydrogenase, Asd Bpr_I1664 C 7.6 × 10−18 5.5 40.1 17 50% Branched-chain amino acid aminotransferase, IlvE Bpr_I1650 C 2.4 × 10−12 5.2 39.2 13 32% Cysteine synthase, CysK Bpr_I1089 C 1.9 × 10−13 5.0 32.3 18 72% Diaminopimelate dehydrogenase Bpr_I0298 C 9.6 × 10−16 5.6 35.8 16 49% Dihydrodipicolinate reductase, DapB Bpr_I2453 C 2.7 × 10−6 4.9 27.0 9 46% Glu/Leu/Phe/Val dehydrogenase Bpr_I2129 C 1.2 × 10−30 5.4 48.6 31 64% Imidazole glycerol phosphate synthase Bpr_I1240 C 8.0 × 10−3 4.7 22.5 8 44% glutamine amidotransferase subunit Ketol-acid reductoisomerase, IlvC Bpr_I1657 C 3.8 × 10−16
    [Show full text]
  • Supplementary Materials
    Supplementary Materials COMPARATIVE ANALYSIS OF THE TRANSCRIPTOME, PROTEOME AND miRNA PROFILE OF KUPFFER CELLS AND MONOCYTES Andrey Elchaninov1,3*, Anastasiya Lokhonina1,3, Maria Nikitina2, Polina Vishnyakova1,3, Andrey Makarov1, Irina Arutyunyan1, Anastasiya Poltavets1, Evgeniya Kananykhina2, Sergey Kovalchuk4, Evgeny Karpulevich5,6, Galina Bolshakova2, Gennady Sukhikh1, Timur Fatkhudinov2,3 1 Laboratory of Regenerative Medicine, National Medical Research Center for Obstetrics, Gynecology and Perinatology Named after Academician V.I. Kulakov of Ministry of Healthcare of Russian Federation, Moscow, Russia 2 Laboratory of Growth and Development, Scientific Research Institute of Human Morphology, Moscow, Russia 3 Histology Department, Medical Institute, Peoples' Friendship University of Russia, Moscow, Russia 4 Laboratory of Bioinformatic methods for Combinatorial Chemistry and Biology, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Moscow, Russia 5 Information Systems Department, Ivannikov Institute for System Programming of the Russian Academy of Sciences, Moscow, Russia 6 Genome Engineering Laboratory, Moscow Institute of Physics and Technology, Dolgoprudny, Moscow Region, Russia Figure S1. Flow cytometry analysis of unsorted blood sample. Representative forward, side scattering and histogram are shown. The proportions of negative cells were determined in relation to the isotype controls. The percentages of positive cells are indicated. The blue curve corresponds to the isotype control. Figure S2. Flow cytometry analysis of unsorted liver stromal cells. Representative forward, side scattering and histogram are shown. The proportions of negative cells were determined in relation to the isotype controls. The percentages of positive cells are indicated. The blue curve corresponds to the isotype control. Figure S3. MiRNAs expression analysis in monocytes and Kupffer cells. Full-length of heatmaps are presented.
    [Show full text]
  • Supplemental Methods
    Supplemental Methods: Sample Collection Duplicate surface samples were collected from the Amazon River plume aboard the R/V Knorr in June 2010 (4 52.71’N, 51 21.59’W) during a period of high river discharge. The collection site (Station 10, 4° 52.71’N, 51° 21.59’W; S = 21.0; T = 29.6°C), located ~ 500 Km to the north of the Amazon River mouth, was characterized by the presence of coastal diatoms in the top 8 m of the water column. Sampling was conducted between 0700 and 0900 local time by gently impeller pumping (modified Rule 1800 submersible sump pump) surface water through 10 m of tygon tubing (3 cm) to the ship's deck where it then flowed through a 156 µm mesh into 20 L carboys. In the lab, cells were partitioned into two size fractions by sequential filtration (using a Masterflex peristaltic pump) of the pre-filtered seawater through a 2.0 µm pore-size, 142 mm diameter polycarbonate (PCTE) membrane filter (Sterlitech Corporation, Kent, CWA) and a 0.22 µm pore-size, 142 mm diameter Supor membrane filter (Pall, Port Washington, NY). Metagenomic and non-selective metatranscriptomic analyses were conducted on both pore-size filters; poly(A)-selected (eukaryote-dominated) metatranscriptomic analyses were conducted only on the larger pore-size filter (2.0 µm pore-size). All filters were immediately submerged in RNAlater (Applied Biosystems, Austin, TX) in sterile 50 mL conical tubes, incubated at room temperature overnight and then stored at -80oC until extraction. Filtration and stabilization of each sample was completed within 30 min of water collection.
    [Show full text]
  • 1/05661 1 Al
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date _ . ... - 12 May 2011 (12.05.2011) W 2 11/05661 1 Al (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every C12Q 1/00 (2006.0 1) C12Q 1/48 (2006.0 1) kind of national protection available): AE, AG, AL, AM, C12Q 1/42 (2006.01) AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, (21) Number: International Application DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, PCT/US20 10/054171 HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, (22) International Filing Date: KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, 26 October 2010 (26.10.2010) ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, (25) Filing Language: English SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, (26) Publication Language: English TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (30) Priority Data: (84) Designated States (unless otherwise indicated, for every 61/255,068 26 October 2009 (26.10.2009) US kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, (71) Applicant (for all designated States except US): ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, MD, RU, TJ, MYREXIS, INC.
    [Show full text]
  • The Microbiota-Produced N-Formyl Peptide Fmlf Promotes Obesity-Induced Glucose
    Page 1 of 230 Diabetes Title: The microbiota-produced N-formyl peptide fMLF promotes obesity-induced glucose intolerance Joshua Wollam1, Matthew Riopel1, Yong-Jiang Xu1,2, Andrew M. F. Johnson1, Jachelle M. Ofrecio1, Wei Ying1, Dalila El Ouarrat1, Luisa S. Chan3, Andrew W. Han3, Nadir A. Mahmood3, Caitlin N. Ryan3, Yun Sok Lee1, Jeramie D. Watrous1,2, Mahendra D. Chordia4, Dongfeng Pan4, Mohit Jain1,2, Jerrold M. Olefsky1 * Affiliations: 1 Division of Endocrinology & Metabolism, Department of Medicine, University of California, San Diego, La Jolla, California, USA. 2 Department of Pharmacology, University of California, San Diego, La Jolla, California, USA. 3 Second Genome, Inc., South San Francisco, California, USA. 4 Department of Radiology and Medical Imaging, University of Virginia, Charlottesville, VA, USA. * Correspondence to: 858-534-2230, [email protected] Word Count: 4749 Figures: 6 Supplemental Figures: 11 Supplemental Tables: 5 1 Diabetes Publish Ahead of Print, published online April 22, 2019 Diabetes Page 2 of 230 ABSTRACT The composition of the gastrointestinal (GI) microbiota and associated metabolites changes dramatically with diet and the development of obesity. Although many correlations have been described, specific mechanistic links between these changes and glucose homeostasis remain to be defined. Here we show that blood and intestinal levels of the microbiota-produced N-formyl peptide, formyl-methionyl-leucyl-phenylalanine (fMLF), are elevated in high fat diet (HFD)- induced obese mice. Genetic or pharmacological inhibition of the N-formyl peptide receptor Fpr1 leads to increased insulin levels and improved glucose tolerance, dependent upon glucagon- like peptide-1 (GLP-1). Obese Fpr1-knockout (Fpr1-KO) mice also display an altered microbiome, exemplifying the dynamic relationship between host metabolism and microbiota.
    [Show full text]
  • A Member of the Polymerase Nucleotidyltransferase Superfamily Is Required for RNA Interference in C. Elegans
    Current Biology, Vol. 15, 378–383, February 22, 2005, ©2005 Elsevier Ltd All rights reserved. DOI 10.1016/j.cub.2005.01.009 A Member of the Polymerase ␤ Nucleotidyltransferase Superfamily Is Required for RNA Interference in C. elegans Chun-Chieh G. Chen,1 Martin J. Simard,1 described mutant mut-2 (r459) [7], suggesting that Hiroaki Tabara,3 Daniel R. Brownell,1,2 mut-2 and rde-3 are allelic. Finally, we found that a PCR Jennifer A. McCollough,1 and Craig C. Mello1,2,* fragment containing only K04F10.6 rescues the somatic 1Program in Molecular Medicine and RNAi defect of ne3364, confirming that K04F10.6 is rde-3 2 Howard Hughes Medical Institute (Figure 1). University of Massachusetts Medical School rde-3 encodes a conserved protein in the polymerase Worcester, Massachusetts 01605 ␤ nucleotidyltransferase superfamily. RDE-3, and other 3 Graduate School of Medicine members in this family, including conventional poly(A) Horizontal Medical Research Organization (HMRO) polymerases (PAP), 2Ј-5Ј oligoadenylate synthetase Kyoto University (OAS), C. elegans GLD-2, and budding yeast Trf4p, all Kyoto 606-8501 contain a nucleotidyltransferase 2 (NTP transferase 2) Japan domain [5]. In addition, RDE-3 and a subset of family members, including GLD-2 and Trf4p, contain an addi- tional domain, of unknown function, named the PAP/ 25A-associated domain [5]. The rde-3 alleles ne298, Summary r459, and fj14 each contain point mutations predicted to alter conserved amino acids. The ne3370 allele con- RNA interference (RNAi) is an ancient, highly con- tains an in-frame deletion of 423 bp (Figure 1B). ne4243 served mechanism in which small RNA molecules and ne3364 each contain nonsense mutations predicted (siRNAs) guide the sequence-specific silencing of to truncate the protein after 164 and 169 amino acids, gene expression [1].
    [Show full text]
  • Insulin Resistance Related Signaling Pathways in the Liver
    INSULIN RESISTANCE RELATED SIGNALING PATHWAYS IN THE LIVER by Yuchun Wang A thesis submitted to Johns Hopkins University in conformity with the requirements for the degree of Master of Science in Engineering Baltimore, Maryland May, 2020 © 2020 Yuchun Wang All rights reserved Abstract Over the past 20 years, the worldwide toll of diabetes has tripled to more than 400 million, which makes it one of the fastest-growing health challenges of the 21st century. There are three main categories of diabetes: type 1, type 2 and gestational diabetes mellitus. Among them, Type 2 diabetes(T2D) makes up to 90% of diabetes worldwide. Hyper- glycemia can be effectively controlled by giving insulin injection for type 1 and gestational diabetes mellitus. However, because insulin resistance is one of the causes of T2D, those with T2D do not respond as well to insulin as those with T1D or gestational diabetes. Fur- thermore, our lack of knowledge about the underlying physiology of T2D makes it difficult to find reliable treatments. While high blood glucose concentration is one of the major symptoms of T2D, changes in lipid metabolism are characteristic of insulin resistance(IR). In the human body, the liver plays a major role in glucose homeostasis and lipid metabolism. Hence, this essay pro- vides an overview of signaling pathways in the liver and presents their interrelationship to better understand the underlying IR mechanism. Primary Reader and Advisor: Marc D. Donohue Secondary Reader: Gregory Aranovich ii Acknowledgements I wish to express my deepest gratitude to my advisor, Professor Marc D. Donohue, for introducing me to the fantastic world of science, and for his patient guidance along the road of my Master’s study.
    [Show full text]
  • Uridylation of Mature Mirnas and Sirnas by the MUT68 Nucleotidyltransferase Promotes Their Degradation in Chlamydomonas
    Uridylation of mature miRNAs and siRNAs by the MUT68 nucleotidyltransferase promotes their degradation in Chlamydomonas Fadia Ibrahima,1, Linda A. Rymarquisb,1, Eun-Jeong Kima, James Beckera, Eniko Balassaa, Pamela J. Greenb, and Heriberto Ceruttia,2 aSchool of Biological Sciences and Center for Plant Science Innovation, University of Nebraska, Lincoln, NE 68588; and bDelaware Biotechnology Institute, University of Delaware, Newark, DE 19711 Edited by James C. Carrington, Oregon State University, Corvallis, OR, and approved December 8, 2009 (received for review November 2, 2009) Regulation of gene expression by small RNAs (∼20–30 nucleotides in 9). Activated RISC uses the remaining single-stranded siRNA as a length) plays an essential role in developmental pathways and guide to identify homologous RNAs, ultimately triggering tran- defense responses against genomic parasites in eukaryotes. Micro- script degradation and/or translation repression (1–3). RNAs (miRNAs) and small interfering RNAs (siRNAs) commonly The biogenesis and the mode of action of sRNAs have direct the inactivation of cognate sequences through a variety of attracted great attention (1–3, 10), but much less is known about mechanisms, including RNA degradation, translation inhibition, and mechanisms of miRNA/siRNA turnover and their role in small transcriptional repression. Recent studies have provided consider- RNA function. Degradation of mature miRNAs in Caeno- able insight into the biogenesis and the mode of action of miRNAs rhabditis elegans, mediated by the 5′-to-3′ exoribonuclease and siRNAs. However, relatively little is known about mechanisms XRN2, has recently been shown to modulate miRNA accumu- of quality control and small RNA decay in RNA interference (RNAi) lation in vivo (11).
    [Show full text]
  • A Review of Isozymes in Cancer1
    Cancer Research VOLUME31 NOVEMBER 1971 NUMBER11 [CANCER RESEARCH 31, 1523-1542, November 1971] A Review of Isozymes in Cancer1 Wayne E. Criss Department of Obstetrics and Gynecology, University of Florida College of Medicine, Gainesville, Florida 32601 TABLE OF CONTENTS postulated role for that particular isozymic system in cellular metabolism. Summary 1523 Introduction 1523 Normal enzyme differentiation 1523 INTRODUCTION Tumor enzyme differentiation 1524 Isozymes 1524 Normal Enzyme Differentiation DNA polymerase 1524 Enzyme differentiation is the process whereby, during the Hexokinase 1525 Fructose 1,6-diphosphatase 1525 development of an organ in an animal, the organ acquires the quantitative and qualitative adult enzyme patterns (122). Key Aldolase 1526 pathway enzymes in several metabolic processes have been Pyruvate kinase 1527 found to undergo enzymatic differentiation. The enzymes Láclatedehydrogenase 1527 Isocitrate dehydrogenase 1527 involved in nitrogen metabolism, and also in urea cycle Malate dehydrogenase 1528 metabolism (180), are tyrosine aminotransferase (123, 151, Glycerol phosphate dehydrogenase 1529 330, 410), tryptophan pyrrolase (261), serine dehydratase Glutaminase 1529 (123, 410), histidine ammonia lyase (11), and aspartate Aspartate aminotransferase 1530 aminotransferase (337, 388). The enzymes involved in nucleic Adenylate kinase 1531 acid metabolism are DNA polymerase (156, 277) and RNase (52). In glycolysis the enzymes are hexokinase-glucokinase Carbamyl phosphate synthetase 1531 Lactose synthetase 1533 (98, 389), galactokinase 30, aldolase (267, 315), pyruvate Discussion 1533 kinase (73, 386), and lactate dehydrogenase (67, 69). In References 1533 mitochondrial oxidation they are NADH oxidase, succinic oxidase, a-glycero-P oxidase, ATPase, cytochrome oxidase, and flavin content (84, 296). In glycogen metabolism the SUMMARY enzymes involved are UDPG pyrophosphorylase and UDPG glucosyltransferase (19).
    [Show full text]
  • Genome-Wide Investigation of Cellular Functions for Trna Nucleus
    Genome-wide Investigation of Cellular Functions for tRNA Nucleus- Cytoplasm Trafficking in the Yeast Saccharomyces cerevisiae DISSERTATION Presented in Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the Graduate School of The Ohio State University By Hui-Yi Chu Graduate Program in Molecular, Cellular and Developmental Biology The Ohio State University 2012 Dissertation Committee: Anita K. Hopper, Advisor Stephen Osmani Kurt Fredrick Jane Jackman Copyright by Hui-Yi Chu 2012 Abstract In eukaryotic cells tRNAs are transcribed in the nucleus and exported to the cytoplasm for their essential role in protein synthesis. This export event was thought to be unidirectional. Surprisingly, several lines of evidence showed that mature cytoplasmic tRNAs shuttle between nucleus and cytoplasm and their distribution is nutrient-dependent. This newly discovered tRNA retrograde process is conserved from yeast to vertebrates. Although how exactly the tRNA nuclear-cytoplasmic trafficking is regulated is still under investigation, previous studies identified several transporters involved in tRNA subcellular dynamics. At least three members of the β-importin family function in tRNA nuclear-cytoplasmic intracellular movement: (1) Los1 functions in both the tRNA primary export and re-export processes; (2) Mtr10, directly or indirectly, is responsible for the constitutive retrograde import of cytoplasmic tRNA to the nucleus; (3) Msn5 functions solely in the re-export process. In this thesis I focus on the physiological role(s) of the tRNA nuclear retrograde pathway. One possibility is that nuclear accumulation of cytoplasmic tRNA serves to modulate translation of particular transcripts. To test this hypothesis, I compared expression profiles from non-translating mRNAs and polyribosome-bound translating mRNAs collected from msn5Δ and mtr10Δ mutants and wild-type cells, in fed or acute amino acid starvation conditions.
    [Show full text]
  • O O2 Enzymes Available from Sigma Enzymes Available from Sigma
    COO 2.7.1.15 Ribokinase OXIDOREDUCTASES CONH2 COO 2.7.1.16 Ribulokinase 1.1.1.1 Alcohol dehydrogenase BLOOD GROUP + O O + O O 1.1.1.3 Homoserine dehydrogenase HYALURONIC ACID DERMATAN ALGINATES O-ANTIGENS STARCH GLYCOGEN CH COO N COO 2.7.1.17 Xylulokinase P GLYCOPROTEINS SUBSTANCES 2 OH N + COO 1.1.1.8 Glycerol-3-phosphate dehydrogenase Ribose -O - P - O - P - O- Adenosine(P) Ribose - O - P - O - P - O -Adenosine NICOTINATE 2.7.1.19 Phosphoribulokinase GANGLIOSIDES PEPTIDO- CH OH CH OH N 1 + COO 1.1.1.9 D-Xylulose reductase 2 2 NH .2.1 2.7.1.24 Dephospho-CoA kinase O CHITIN CHONDROITIN PECTIN INULIN CELLULOSE O O NH O O O O Ribose- P 2.4 N N RP 1.1.1.10 l-Xylulose reductase MUCINS GLYCAN 6.3.5.1 2.7.7.18 2.7.1.25 Adenylylsulfate kinase CH2OH HO Indoleacetate Indoxyl + 1.1.1.14 l-Iditol dehydrogenase L O O O Desamino-NAD Nicotinate- Quinolinate- A 2.7.1.28 Triokinase O O 1.1.1.132 HO (Auxin) NAD(P) 6.3.1.5 2.4.2.19 1.1.1.19 Glucuronate reductase CHOH - 2.4.1.68 CH3 OH OH OH nucleotide 2.7.1.30 Glycerol kinase Y - COO nucleotide 2.7.1.31 Glycerate kinase 1.1.1.21 Aldehyde reductase AcNH CHOH COO 6.3.2.7-10 2.4.1.69 O 1.2.3.7 2.4.2.19 R OPPT OH OH + 1.1.1.22 UDPglucose dehydrogenase 2.4.99.7 HO O OPPU HO 2.7.1.32 Choline kinase S CH2OH 6.3.2.13 OH OPPU CH HO CH2CH(NH3)COO HO CH CH NH HO CH2CH2NHCOCH3 CH O CH CH NHCOCH COO 1.1.1.23 Histidinol dehydrogenase OPC 2.4.1.17 3 2.4.1.29 CH CHO 2 2 2 3 2 2 3 O 2.7.1.33 Pantothenate kinase CH3CH NHAC OH OH OH LACTOSE 2 COO 1.1.1.25 Shikimate dehydrogenase A HO HO OPPG CH OH 2.7.1.34 Pantetheine kinase UDP- TDP-Rhamnose 2 NH NH NH NH N M 2.7.1.36 Mevalonate kinase 1.1.1.27 Lactate dehydrogenase HO COO- GDP- 2.4.1.21 O NH NH 4.1.1.28 2.3.1.5 2.1.1.4 1.1.1.29 Glycerate dehydrogenase C UDP-N-Ac-Muramate Iduronate OH 2.4.1.1 2.4.1.11 HO 5-Hydroxy- 5-Hydroxytryptamine N-Acetyl-serotonin N-Acetyl-5-O-methyl-serotonin Quinolinate 2.7.1.39 Homoserine kinase Mannuronate CH3 etc.
    [Show full text]